- Record: found
- Abstract: not found
- Article: not found
Randomized phase II trial of intravenous RO5137382/GC33 at 1600 mg every other week and placebo in previously treated patients with unresectable advanced hepatocellular carcinoma (HCC; NCT01507168).
Chia-Jui Yen, Bruno Daniele, Masatoshi Kudo, Philippe Merle, Joong-Won Park, Paul Ross, Jean-Marie Péron, Oliver Ebert, Stephen Chan, Ronnie Tung-Ping Poon, Massimo Colombo, Takuji Okusaka, Baek-Yeol Ryoo, Beatriz Minguez, Takayoshi Tanaka, Toshihiko Ohtomo, Olga Rutman, Ya-Chi Chen, Reuy-min Lee, Ghassan Abou-Alfa, CJ YEN, B Daniele, M KUDO, P. Merle, JW Park, P. Ross, JO Péron, O Ebert, S. CHAN, RT Poon
2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.